يعرض 1 - 10 نتائج من 14 نتيجة بحث عن '"M. Mattijssen"', وقت الاستعلام: 2.04s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Tumour Virus Research, Vol 13, Iss , Pp 200233- (2022)

    وصف الملف: electronic resource

  2. 2
  3. 3
  4. 4
  5. 5

    المساهمون: Health Technology Assessment (HTA), MUMC+: MA Medische Oncologie (9), Onderwijs instituut FHML, RS: GROW - Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, AII - Amsterdam institute for Infection and Immunity, CCA -Cancer Center Amsterdam, Clinical Haematology, Hematology, CCA - Quality of life

    المصدر: Quality of Life Research, 24(12), 2895-2906. Springer Netherlands
    Quality of Life Research, 24(12), 2895-2906. SPRINGER
    Holtzer-Goor, K M, Schaafsma, M R, Joosten, P, Posthuma, E F M, Wittebol, S, Huijgens, P C, Mattijssen, E J M, Vreugdenhil, G, Visser, H, Peters, W G, Erjavec, Z, Wijermans, P W, Daenen, S M G J, van der Hem, K G, van Oers, M H J & Uyl-de Groot, C A 2015, ' Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study ', Quality of Life Research, vol. 24, no. 12, pp. 2895-2906 . https://doi.org/10.1007/s11136-015-1039-y
    Quality of Life Research, 24(12), 2895-2906. Springer, Cham
    Quality of Life Research
    Quality of life research, 24(12), 2895-2906. Springer Netherlands

    وصف الملف: application/pdf

  6. 6
    دورية أكاديمية
  7. 7

    المؤلفون: J. Weel, P. Oostvogel, I. Molenaar, Audrey J. King, J. Schirm, E. Doorn, Petra F. G. Wolffs, Christian J. P. A. Hoebe, M. van de Pas, I. de Koning, J. Janssen, A. Gelissen-Hansen, M. Illidge-Onder de Linden, P. Sanders, M. Hooghiemstra, J. Kiewiet, Han S. A. Fennema, C. de Mooij, P. Hut-van Vliet, S. Lakbiach, Dirk S. Luijt, M. Pelsers, F. De Groot, T. van Zwet, M. Wolfhagen, H. Huisman, C. van Ruitenbeek, L. Masthoff, C. Touwen, H. Verbakel, Antoinette A. T. P. Brink, M. Schutten, K. Adams, I. Hondelink, N. Duijvendijk, R. Tiemessen, A.G.M. Buiting, Arjan Hogewoning, Robine Donken, Antoine M Beerens, T. de Haas, F. Postma, M. de Graas, F. Verduyn-Lunel, Jaco J. Verweij, Peter M. Schneeberger, T. Taconis, Titia Heijman, V. Sigurdsson, D. Adema, Elfi E. H. G. Brouwers, Petra J. Woestenberg, Menke J. de Smit, Johannes A. Bogaards, E. Pannekoek, E. van Koolwijk, I. Linde, P. Cornelissen, W. Vermeulen, C. van Bokhoven-Rombouts, Sylvia M. Bruisten, A. van Leeuwen, W. de Waal, R. Huisman, Marianne A B van der Sande, G. Aalfs, A. Botraby, Marcel Peeters, Hannelore M Götz, D. Abma, A.A. van der Eijk, R. Buist-Arkema, H. Korff, H. Bosch, C. de Haan, M. van Rooijen, H. van Buel-Bruins, S. Meijer, P. van Goor, E. Swaders, Fiona R. M. van der Klis, P. van Esch, M. Mattijssen, I. Polman, Birgit H B van Benthem, M. Dinnissen-van Poppel, J. Stam, John W. A. Rossen, Caroline M. A. Swanink, Rob Schuurman, T. Smits, J. Nelissen, C. Kampman, M. Peters, Willem J. G. Melchers, M. Pelgrim, C. Kerkhof, J. Velzing, Suzan Leussink, H. van Kruchten, D. Bukasa, P. van Rosmalen, Y. Poort, F. Neienhuijsen, M. Kersten, Anne-Marie Niekamp, R. Kleinspenkelink

    المساهمون: CCA - Cancer biology and immunology, AII - Infectious diseases, Pathology, APH - Methodology, Other departments, APH - Global Health, Medical Microbiology and Infection Prevention, Neurology, Promovendi PHPC, Med Microbiol, Infect Dis & Infect Prev, RS: CAPHRI - R4 - Health Inequities and Societal Participation

    المصدر: Journal of Infection, 74(4), 393-400. W.B. Saunders Ltd
    Journal of infection, 74(4), 393-400. W.B. Saunders Ltd
    Journal of Infection, 74(4), 393-400. Elsevier Saunders
    The Journal of Infection, 74(4), 393. W.B. Saunders Ltd
    Woestenberg, P J, King, A J, van der Sande, M A B, Donken, R, Leussink, S, van der Klis, F R M, Hoebe, C J P A, Bogaards, J A, van Benthem, B H B, Medical Microbiological Laboratories & Public Health Services 2017, ' No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors ', Journal of Infection, vol. 74, no. 4, pp. 393-400 . https://doi.org/10.1016/j.jinf.2017.01.007

    وصف الملف: image/pdf

  8. 8

    المساهمون: Hematology, CCA - Clinical Therapy Development, Internal medicine, Interne Geneeskunde, MUMC+: MA Hematologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: Zweegman, S, van der Holt, B, Mellqvist, U-H, Salomo, M, Bos, G M J, Levin, M-D, Visser-Wisselaar, H, Hansson, M, van der Velden, A W G, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S K, Tanis, B C, Szatkowski, D L, Brouwer, R E, Westerman, M, Leys, M R B L, Sinnige, H A M, Haukås, E, van der Hem, K G, Durian, M F, Mattijssen, E V J M, van de Donk, N W C J, Stevens-Kroef, M J P L, Sonneveld, P & Waage, A 2016, ' Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma ', Blood, vol. 127, no. 9, pp. 1109-1116 . https://doi.org/10.1182/blood-2015-11-679415
    Blood, 127(9), 1109-1116. American Society of Hematology
    Blood, 127(9), 1109-1116. The American Society of Hematology
    Zweegman, S, van der Holt, B, Mellqvist, U-H, Salomo, M, Bos, G M J, Levin, M-D, Visser-Wisselaar, H, Hansson, M, van der Velden, A W G, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S K, Tanis, B C, Szatkowski, D L, Brouwer, R E, Westerman, M, Leys, M B L, Sinnige, H A M, Haukas, E, van der Hem, K G, Durian, M F, Mattijssen, E J M, van de Donk, N W C J, Stevens-Kroef, M J P L, Sonneveld, P & Waage, A 2016, ' Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma ', Blood, vol. 127, no. 9, pp. 1109-1116 . https://doi.org/10.1182/blood-2015-11-679415
    Blood, 127, 1109-16
    Blood, 127, 9, pp. 1109-16

  9. 9
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  10. 10

    المساهمون: MUMC+: MA Medische Oncologie (9), Onderwijs instituut FHML, RS: GROW - Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Health Economics (HE), Erasmus MC other, Hematology, CCA - Innovative therapy, Amsterdam institute for Infection and Immunity, Cancer Center Amsterdam, Clinical Haematology

    المصدر: Leukemia Research, 38(1), 84-90. Elsevier Limited
    Leukemia Research, 38(1), 84-90
    Leukemia Research, 38(1), 84-90. PERGAMON-ELSEVIER SCIENCE LTD
    Leukemia Research, 38, 84-90. Elsevier Ltd.
    Leukemia research, 38(1), 84-90. Elsevier Limited
    Holtzer-Goor, K M, Bouwmans-Frijters, C A M, Schaafsma, M R, de Weerdtc, O, Joosten, P, Posthuma, E F M, Wittebol, S, Huijgens, P C, Matthssen, E J M, Vreugdenhil, G, Visser, H, Peters, W G, Erjavec, Z, Wijermans, P W, Daenen, S M G J, van der Hem, K G, van Oers, M H J & Uyl-de Groot, C A 2014, ' Real-world costs of chronic lymphocytic leukaemia in the Netherlands ', Leukemia Research, vol. 38, no. 1, pp. 84-90 . https://doi.org/10.1016/j.leukres.2013.10.029